[14–17] In metastatic colorectal cancer elevated levels of Interleukin 6, CRP and the NLR emerged as predictors of impaired disease outcome, whereas high levels of LMR seem to be associated with prolonged survival. The gene discussed is IL6; the disease is metastatic colorectal cancer.